Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol

Background: Deep vein thrombosis (DVT) has been reported as an adverse event for patients receiving combined oral contraceptives. Norethindrone/ethinyl estradiol (NET/EE) and drospirenone/ethinyl estradiol (DRSP/EE) are two commonly prescribed combined hormonal oral contraceptive agents used in the...

詳細記述

書誌詳細

主要な著者:	Jennifer Stalas, Robert Morris, Kun Bu, Kevin von Bargen, Rebekah Largmann, Kathryn Sanford, Jacob Vandeventer, Weiru Han, Feng Cheng
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-03-01
シリーズ:	Heliyon
主題:	FAERS DVT DRSP Pharmacovigilance Drug-drug interactions DDI
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2405844024024939
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!